Related Experiment Video
Updated: May 8, 2026
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
IMWG consensus on risk stratification in multiple myeloma
W J Chng1, A Dispenzieri2, C-S Chim3
11] Department of Haematology Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore [2] Experimental Therapeutics, Cancer Science Institute of Singapore, Singapore, Singapore [3] Department of Medicine, Yoo Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
This consensus statement proposes standardized risk categories for multiple myeloma patients. These categories will help stratify patients and guide personalized treatment strategies for better outcomes.
Area of Science:
- Hematology
- Oncology
- Clinical Medicine
Background:
- Multiple myeloma exhibits significant clinical and biological heterogeneity, leading to varied treatment responses and outcomes.
- The expanding therapeutic landscape necessitates mechanisms to address this heterogeneity and personalize treatment.
- Validated prognostic markers are crucial for stratifying patients into distinct risk groups.
Purpose of the Study:
- To propose well-defined and applicable risk categories for multiple myeloma.
- To establish gold-standard prognostic factors for clinical trials.
- To provide a framework for rationalizing therapeutic approaches.
Main Methods:
- Consensus statement development by the International Myeloma Working Group.
- Review of current validated prognostic markers.
- Proposal of standardized risk stratification categories.
Main Results:
- Defined easily applicable risk categories for multiple myeloma.
- Recommended prognostic factors as gold standards for clinical trials.
- Established a framework for rationalizing therapy selection.
Conclusions:
- Standardized risk categories are essential for managing multiple myeloma heterogeneity.
- These categories will guide treatment decisions and improve patient outcomes.
- The proposed framework supports the development of advanced prognostic systems.